PERSPECTA

News from every angle

← Back to headlines

Biotech Fund Sells Nuvalent Shares After 29% Stock Surge

A biotech fund has divested $84 million worth of Nuvalent shares, despite the stock experiencing a 29% increase.

23 Feb, 15:21 — 23 Feb, 15:21
PostShare
Only 1 source covers this story